Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis

May 15, 2025 | Comments Off on Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis

Cancers 2025 March 14 [Link] Jenny Zipprick, Enes Demir, Hanna Krynska, Sıla Köprülüoğlu, Katharina Strauß, Marcus Skribek, Rita Hutyra-Gram Ötvös, Annica K B Gad, Katalin Dobra Abstract Background/objectives: Non-small cell…

DNA methylation-regulated HLA-C expression modulates immune responses and metabolic alterations to influence prognosis in mesothelioma

May 14, 2025 | Comments Off on DNA methylation-regulated HLA-C expression modulates immune responses and metabolic alterations to influence prognosis in mesothelioma

Cancer Immunology, Immunotherapy 2025 March 25 [Link] Huilin Zhang, Luanxue Yu, Yunqing Guo, Jiawei Ming, Zhenying Guo Abstract Background: Malignant mesothelioma is a highly aggressive cancer with a poor prognosis…

A woman with a pleural mesothelioma and an inherited ATM mutation-a case report

May 13, 2025 | Comments Off on A woman with a pleural mesothelioma and an inherited ATM mutation-a case report

Annals of Translational Medicine 2025 February 28 [Link] Marta Seca, B C John Cho, Angelina Tryon, Steven A Narod Abstract Background: Pleural mesothelioma (PM) is a rare and aggressive malignancy…

New soluble CSF-1R-dimeric mutein with enhanced trapping of both CSF-1 and IL-34 reduces suppressive tumor-associated macrophages in pleural mesothelioma

May 12, 2025 | Comments Off on New soluble CSF-1R-dimeric mutein with enhanced trapping of both CSF-1 and IL-34 reduces suppressive tumor-associated macrophages in pleural mesothelioma

Journal for Immunotherapy of Cancer 2025 March 17 [Link] Noémie Joalland, Agnès Quéméner, Sophie Deshayes, Romain Humeau, Mike Maillasson, Héloïse LeBihan, Apolline Salama, Judith Fresquet, Séverine Remy, Erwan Mortier, Christophe…

New soluble CSF-1R-dimeric mutein with enhanced trapping of both CSF-1 and IL-34 reduces suppressive tumor-associated macrophages in pleural mesothelioma

May 9, 2025 | Comments Off on New soluble CSF-1R-dimeric mutein with enhanced trapping of both CSF-1 and IL-34 reduces suppressive tumor-associated macrophages in pleural mesothelioma

Journal for Immunotherapy for Cancer 2025 March 17 [Link] Noémie Joalland, Agnès Quéméner, Sophie Deshayes, Romain Humeau, Mike Maillasson, Héloïse LeBihan, Apolline Salama, Judith Fresquet, Séverine Remy, Erwan Mortier, Christophe…

PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapy

May 8, 2025 | Comments Off on PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapy

Non-Coding RNA Research 2025 February 21 [Link] Andrei Gurau, Suguru Yamauchi, Kaitlyn Ecoff, Kristen P Rodgers, James R Eshleman, Charles Conover Talbot Jr, Peng Huang, Joshua Choi, Patrick M Forde,…

Development and validation of a prognostic nomogram for patients with malignant peritoneal mesothelioma

May 7, 2025 | Comments Off on Development and validation of a prognostic nomogram for patients with malignant peritoneal mesothelioma

Frontiers in Oncology 2025 February 28 [Link] Xiaohan Wang, RuiTing Liu, Chunli Wang, Jingjing Sun, Dongliang Yang Abstract Background: Malignant peritoneal mesothelioma(MPM) is a highly aggressive malignant tumor that originates…

Prognostic Value of Chest CT Volumetric Analysis in Patients with Malignant Pleural Mesothelioma

May 6, 2025 | Comments Off on Prognostic Value of Chest CT Volumetric Analysis in Patients with Malignant Pleural Mesothelioma

Journal of Clinical Medicine 2025 February 25 [Link] Elisa Baratella, Eleonora Ercolani, Antonio Segalotti, Marina Troian, Stefano Lovadina, Fabiola Giudici, Pierluca Minelli, Barbara Ruaro, Francesco Salton, Maria Assunta Cova Abstract…

Potent and durable control of mesothelin-expressing tumors by a novel T cell-secreted bi-specific engager

May 5, 2025 | Comments Off on Potent and durable control of mesothelin-expressing tumors by a novel T cell-secreted bi-specific engager

Journal for Immunotherapy for Cancer 2025 March 13 [Link] Paris Kosti, Johan Abram-Saliba, Laetitia Pericou-Troquier, Sarah Pavelot, Tiphaine Ruggeri, Marc Laffaille, Melita Irving, George Coukos, Evripidis Lanitis, Steven M Dunn…

Mesothelioma cell heterogeneity identified by single cell RNA sequencing

May 2, 2025 | Comments Off on Mesothelioma cell heterogeneity identified by single cell RNA sequencing

Scientific Reports 2025 March 13 [Link] Licun Wu, Zongjie Wang, Amin Zia, Shana O Kelley, Marc de Perrot Abstract Mesothelioma cell heterogeneity encompasses diverse morphological and molecular characteristics observed within…

Categories